Show
Sort by
-
Efficacy and safety of Bimagrumab in sporadic inclusion body myositis : long-term extension of RESILIENT
-
- Journal Article
- A1
- open access
Efficacy and safety of rozanolixizumab in moderate to severe generalized myasthenia gravis : a phase 2 randomized control trial
-
- Journal Article
- A1
- open access
Late-onset Pompe disease (LOPD) in Belgium : clinical characteristics and outcome measures
-
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT) : a randomised, double-blind, placebo-controlled phase 2b trial
-
- Journal Article
- A1
- open access
Alternative approach to populate and study the Th-229 nuclear clock isomer
-
- Journal Article
- A1
- open access
Detailed α-decay study of 180Tl
-
Database crossing allows better understanding of neuromuscular disorders epidemiology: the Belgian example
-
How robust is ACTIVLIM for the follow-up of activity limitations in patients with neuromuscular diseases?
-
- Journal Article
- A1
- open access
Early stages of building a rare disease registry, methods and 2010 data from the Belgian Neuromuscular Disease Registry (BNMDR)
-
- Journal Article
- A1
- open access
β-delayed fission of 180Tl